Literature DB >> 10398433

Delineation of multiple deleted regions in 7q in myeloid disorders.

S Tosi1, S W Scherer, G Giudici, B Czepulkowski, A Biondi, L Kearney.   

Abstract

Loss of chromosome material due to deletions of the long arm of chromosome 7, del(7q), is a consistent finding in all types of myeloid disorders, invariably associated with a poor prognosis. Two different segments, 7q22 and 7q32-q33, have been implicated as critical regions of gene loss associated with these disorders. In the present study, we used fluorescence in situ hybridization (FISH) to characterize the 7q22 breakpoint of an apparently balanced t(7;7)(p13;q22) in an acute myeloid leukemia patient. FISH analysis on bone marrow metaphases from this patient revealed that the sequence corresponding to a series of three ordered cosmids from 7q22 was deleted from one of the der(7) chromosomes. These cosmids contain the human homologue of the Drosophila homeobox gene cut (CUTL1) and span a region of approximately 150 kb. Although the proximal boundary of the deleted segment could not be exactly defined, we estimate the size of this deletion to be approximately 500 kb. Subsequently, we carried out FISH studies using the CUTL1 cosmids on a further 16 patients with deletions of 7q and myeloid disorders. The sequence corresponding to at least two of the cosmids was deleted from the del(7q) in 11 out of 14 cases with a proximal breakpoint within 7q22. Further detailed FISH mapping in this series of 17 patients has identified two other nonoverlapping commonly deleted segments at 7q31-q32 and 7q33, respectively. These data confirm and refine other studies, implying that several different genes on 7q may be involved in the pathogenesis of myeloid diseases. Genes Chromosomes Cancer 25:384-392, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10398433     DOI: 10.1002/(sici)1098-2264(199908)25:4<384::aid-gcc11>3.0.co;2-d

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.

Authors:  Jasmine C Y Wong; Yan Zhang; Kenneth H Lieuw; Mary T Tran; Erna Forgo; Kelley Weinfurtner; Pilar Alzamora; Scott C Kogan; Keiko Akagi; Linda Wolff; Michelle M Le Beau; Nigel Killeen; Kevin Shannon
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

Review 2.  Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis.

Authors:  S J Knight; J Flint
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

3.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

4.  Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.

Authors:  Ying Jiang; Andrew Dunbar; Lukasz P Gondek; Sanjay Mohan; Manjot Rataul; Christine O'Keefe; Mikkael Sekeres; Yogen Saunthararajah; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

5.  DOCK4 deletion at 7q31.1 in a de novo acute myeloid leukemia with a normal karyotype.

Authors:  Eigil Kjeldsen; Christopher Veigaard
Journal:  Cell Oncol (Dordr)       Date:  2013-08-27       Impact factor: 6.730

6.  An optimized set of human telomere clones for studying telomere integrity and architecture.

Authors:  S J Knight; C M Lese; K S Precht; J Kuc; Y Ning; S Lucas; R Regan; M Brenan; A Nicod; N M Lawrie; D L Cardy; H Nguyen; T J Hudson; H C Riethman; D H Ledbetter; J Flint
Journal:  Am J Hum Genet       Date:  2000-06-22       Impact factor: 11.043

7.  Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis.

Authors:  Jasmine C Wong; Kelley M Weinfurtner; Maria Del Pilar Alzamora; Scott C Kogan; Michael R Burgess; Yan Zhang; Joy Nakitandwe; Jing Ma; Jinjun Cheng; Shann-Ching Chen; Theodore T Ho; Johanna Flach; Damien Reynaud; Emmanuelle Passegué; James R Downing; Kevin Shannon
Journal:  Elife       Date:  2015-07-20       Impact factor: 8.140

Review 8.  Cytogenetic features in myelodysplastic syndromes.

Authors:  Detlef Haase
Journal:  Ann Hematol       Date:  2008-04-15       Impact factor: 3.673

9.  Novel evolutionary models and periodic charts in p- and q-individual chromosomes of auxiliary lymph node and buccal cells.

Authors:  P Mehdipour; F Javan; M Atri
Journal:  Dis Markers       Date:  2013-11-28       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.